Global Drug Eluting Stents (DES) Competitive Landscape Professional Research Report 2025
Description
Research Summary
Drug-eluting stents (DES) are medical devices used in the treatment of coronary artery disease. They are tiny, wire mesh tubes that are implanted in narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty. What sets DES apart from traditional bare-metal stents is their coating with a medication, usually an anti-proliferative drug, that is slowly released over time. This drug helps inhibit the growth of cells that can lead to restenosis (re-narrowing) of the treated artery. By combining the mechanical support of the stent with the therapeutic effects of the drug, DES have significantly reduced the rate of restenosis compared to bare-metal stents. They play a crucial role in improving blood flow to the heart and reducing the need for repeat procedures in patients with coronary artery disease.
According to DIResearch's in-depth investigation and research, the global Drug Eluting Stents (DES) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Drug Eluting Stents (DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen, Biosensors, Biotronik, Blue Medical, DISA Vascular, Boston Scientific, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Promed Medical, Orbusneich, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drug Eluting Stents (DES). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Eluting Stents (DES) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Eluting Stents (DES) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Eluting Stents (DES) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drug Eluting Stents (DES) Include:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen
Biosensors
Biotronik
Blue Medical
DISA Vascular
Boston Scientific
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Promed Medical
Orbusneich
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Drug Eluting Stents (DES) Product Segment Include:
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Drug Eluting Stents (DES) Product Application Include:
Coronary Artery Disease (CAD)
Acute Coronary Syndrome (ACS)
Stable Angina
Chronic Total Occlusion
Left Main Coronary Artery Disease
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drug Eluting Stents (DES) Industry PESTEL Analysis
Chapter 3: Global Drug Eluting Stents (DES) Industry Porter’s Five Forces Analysis
Chapter 4: Global Drug Eluting Stents (DES) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Drug Eluting Stents (DES) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drug Eluting Stents (DES) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Drug-eluting stents (DES) are medical devices used in the treatment of coronary artery disease. They are tiny, wire mesh tubes that are implanted in narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty. What sets DES apart from traditional bare-metal stents is their coating with a medication, usually an anti-proliferative drug, that is slowly released over time. This drug helps inhibit the growth of cells that can lead to restenosis (re-narrowing) of the treated artery. By combining the mechanical support of the stent with the therapeutic effects of the drug, DES have significantly reduced the rate of restenosis compared to bare-metal stents. They play a crucial role in improving blood flow to the heart and reducing the need for repeat procedures in patients with coronary artery disease.
According to DIResearch's in-depth investigation and research, the global Drug Eluting Stents (DES) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Drug Eluting Stents (DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen, Biosensors, Biotronik, Blue Medical, DISA Vascular, Boston Scientific, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Promed Medical, Orbusneich, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drug Eluting Stents (DES). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Eluting Stents (DES) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Eluting Stents (DES) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Eluting Stents (DES) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drug Eluting Stents (DES) Include:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen
Biosensors
Biotronik
Blue Medical
DISA Vascular
Boston Scientific
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Promed Medical
Orbusneich
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Drug Eluting Stents (DES) Product Segment Include:
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Drug Eluting Stents (DES) Product Application Include:
Coronary Artery Disease (CAD)
Acute Coronary Syndrome (ACS)
Stable Angina
Chronic Total Occlusion
Left Main Coronary Artery Disease
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drug Eluting Stents (DES) Industry PESTEL Analysis
Chapter 3: Global Drug Eluting Stents (DES) Industry Porter’s Five Forces Analysis
Chapter 4: Global Drug Eluting Stents (DES) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Drug Eluting Stents (DES) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drug Eluting Stents (DES) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Drug Eluting Stents (DES) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Drug Eluting Stents (DES) Product by Type
- 1.2.1 Cobalt-chromium Alloy Stents
- 1.2.2 Magnesium Alloy Stents
- 1.2.3 Tyrosine Polycarbonate Stents
- 1.2.4 Nitinol Stents
- 1.2.5 Platinum Chromium Alloy Stents
- 1.2.6 Stainless Steel Stents
- 1.2.7 Other Materials
- 1.3 Drug Eluting Stents (DES) Product by Application
- 1.3.1 Coronary Artery Disease (CAD)
- 1.3.2 Acute Coronary Syndrome (ACS)
- 1.3.3 Stable Angina
- 1.3.4 Chronic Total Occlusion
- 1.3.5 Left Main Coronary Artery Disease
- 1.3.6 Other
- 1.4 Global Drug Eluting Stents (DES) Market Revenue and Sales Analysis
- 1.4.1 Global Drug Eluting Stents (DES) Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Drug Eluting Stents (DES) Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Drug Eluting Stents (DES) Market Sales Price Trend Analysis (2020-2032)
- 1.5 Drug Eluting Stents (DES) Industry Trends and Innovation
- 1.5.1 Drug Eluting Stents (DES) Industry Trends and Innovation
- 1.5.2 Drug Eluting Stents (DES) Market Drivers and Challenges
- 2 Drug Eluting Stents (DES) Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Drug Eluting Stents (DES) Market Analysis by Regions
- 4.1 Global Drug Eluting Stents (DES) Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Drug Eluting Stents (DES) Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Drug Eluting Stents (DES) Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Drug Eluting Stents (DES) Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Drug Eluting Stents (DES) Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Drug Eluting Stents (DES) Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Drug Eluting Stents (DES) Sales and Market Share Forecast by Region (2026-2032)
- 4.4 Global Drug Eluting Stents (DES) Sales Price Trend Analysis (2020-2032)
- 5 Global Drug Eluting Stents (DES) Market Size by Type and Application
- 5.1 Global Drug Eluting Stents (DES) Market Size by Type
- 5.1.1 Global Drug Eluting Stents (DES) Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Drug Eluting Stents (DES) Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Drug Eluting Stents (DES) Market Size by Application
- 5.2.1 Global Drug Eluting Stents (DES) Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Drug Eluting Stents (DES) Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Drug Eluting Stents (DES) Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Drug Eluting Stents (DES) Market Size by Type
- 6.3.1 North America Drug Eluting Stents (DES) Sales by Type (2020-2032)
- 6.3.2 North America Drug Eluting Stents (DES) Revenue by Type (2020-2032)
- 6.4 North America Drug Eluting Stents (DES) Market Size by Application
- 6.4.1 North America Drug Eluting Stents (DES) Sales by Application (2020-2032)
- 6.4.2 North America Drug Eluting Stents (DES) Revenue by Application (2020-2032)
- 6.5 North America Drug Eluting Stents (DES) Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Drug Eluting Stents (DES) Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Drug Eluting Stents (DES) Market Size by Type
- 7.3.1 Europe Drug Eluting Stents (DES) Sales by Type (2020-2032)
- 7.3.2 Europe Drug Eluting Stents (DES) Revenue by Type (2020-2032)
- 7.4 Europe Drug Eluting Stents (DES) Market Size by Application
- 7.4.1 Europe Drug Eluting Stents (DES) Sales by Application (2020-2032)
- 7.4.2 Europe Drug Eluting Stents (DES) Revenue by Application (2020-2032)
- 7.5 Europe Drug Eluting Stents (DES) Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Drug Eluting Stents (DES) Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Drug Eluting Stents (DES) Market Size by Type
- 8.3.1 China Drug Eluting Stents (DES) Sales by Type (2020-2032)
- 8.3.2 China Drug Eluting Stents (DES) Revenue by Type (2020-2032)
- 8.4 China Drug Eluting Stents (DES) Market Size by Application
- 8.4.1 China Drug Eluting Stents (DES) Sales by Application (2020-2032)
- 8.4.2 China Drug Eluting Stents (DES) Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Drug Eluting Stents (DES) Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Drug Eluting Stents (DES) Market Size by Type
- 9.3.1 APAC (excl. China) Drug Eluting Stents (DES) Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Drug Eluting Stents (DES) Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Drug Eluting Stents (DES) Market Size by Application
- 9.4.1 APAC (excl. China) Drug Eluting Stents (DES) Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Drug Eluting Stents (DES) Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Drug Eluting Stents (DES) Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Drug Eluting Stents (DES) Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Drug Eluting Stents (DES) Market Size by Type
- 10.3.1 Latin America Drug Eluting Stents (DES) Sales by Type (2020-2032)
- 10.3.2 Latin America Drug Eluting Stents (DES) Revenue by Type (2020-2032)
- 10.4 Latin America Drug Eluting Stents (DES) Market Size by Application
- 10.4.1 Latin America Drug Eluting Stents (DES) Sales by Application (2020-2032)
- 10.4.2 Latin America Drug Eluting Stents (DES) Revenue by Application (2020-2032)
- 10.5 Latin America Drug Eluting Stents (DES) Market Size by Country
- 10.6 Latin America Drug Eluting Stents (DES) Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Drug Eluting Stents (DES) Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Drug Eluting Stents (DES) Market Size by Type
- 11.3.1 Middle East & Africa Drug Eluting Stents (DES) Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Drug Eluting Stents (DES) Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Drug Eluting Stents (DES) Market Size by Application
- 11.4.1 Middle East & Africa Drug Eluting Stents (DES) Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Drug Eluting Stents (DES) Revenue by Application (2020-2032)
- 11.5 Middle East Drug Eluting Stents (DES) Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Drug Eluting Stents (DES) Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Drug Eluting Stents (DES) Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Drug Eluting Stents (DES) Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Drug Eluting Stents (DES) Average Sales Price by Manufacturers (2021-2025)
- 12.2 Drug Eluting Stents (DES) Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Drug Eluting Stents (DES) Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Abbott Vascular
- 13.1.1 Abbott Vascular Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Portfolio
- 13.1.3 Abbott Vascular Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Advantec Vascular
- 13.2.1 Advantec Vascular Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Portfolio
- 13.2.3 Advantec Vascular Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 B.Braun Melsengen
- 13.3.1 B.Braun Melsengen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 B.Braun Melsengen Drug Eluting Stents (DES) Product Portfolio
- 13.3.3 B.Braun Melsengen Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Biosensors
- 13.4.1 Biosensors Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Biosensors Drug Eluting Stents (DES) Product Portfolio
- 13.4.3 Biosensors Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Biotronik
- 13.5.1 Biotronik Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Biotronik Drug Eluting Stents (DES) Product Portfolio
- 13.5.3 Biotronik Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Blue Medical
- 13.6.1 Blue Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Blue Medical Drug Eluting Stents (DES) Product Portfolio
- 13.6.3 Blue Medical Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 DISA Vascular
- 13.7.1 DISA Vascular Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 DISA Vascular Drug Eluting Stents (DES) Product Portfolio
- 13.7.3 DISA Vascular Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Boston Scientific
- 13.8.1 Boston Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Boston Scientific Drug Eluting Stents (DES) Product Portfolio
- 13.8.3 Boston Scientific Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Essen
- 13.9.1 Essen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Essen Drug Eluting Stents (DES) Product Portfolio
- 13.9.3 Essen Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Medtronic Vascular
- 13.10.1 Medtronic Vascular Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Portfolio
- 13.10.3 Medtronic Vascular Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 MicroPort Medical
- 13.11.1 MicroPort Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Portfolio
- 13.11.3 MicroPort Medical Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 MIV Therapeutics
- 13.12.1 MIV Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Portfolio
- 13.12.3 MIV Therapeutics Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Promed Medical
- 13.13.1 Promed Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Promed Medical Drug Eluting Stents (DES) Product Portfolio
- 13.13.3 Promed Medical Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Orbusneich
- 13.14.1 Orbusneich Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Orbusneich Drug Eluting Stents (DES) Product Portfolio
- 13.14.3 Orbusneich Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.15 Relisys Medical
- 13.15.1 Relisys Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Relisys Medical Drug Eluting Stents (DES) Product Portfolio
- 13.15.3 Relisys Medical Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.16 Reva Medical
- 13.16.1 Reva Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Reva Medical Drug Eluting Stents (DES) Product Portfolio
- 13.16.3 Reva Medical Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.17 Sahajanand
- 13.17.1 Sahajanand Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Sahajanand Drug Eluting Stents (DES) Product Portfolio
- 13.17.3 Sahajanand Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.18 Sino Medical
- 13.18.1 Sino Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Sino Medical Drug Eluting Stents (DES) Product Portfolio
- 13.18.3 Sino Medical Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.19 Sorin
- 13.19.1 Sorin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Sorin Drug Eluting Stents (DES) Product Portfolio
- 13.19.3 Sorin Drug Eluting Stents (DES) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Drug Eluting Stents (DES) Industry Chain Analysis
- 14.2 Drug Eluting Stents (DES) Industry Raw Material and Suppliers Analysis
- 14.2.1 Drug Eluting Stents (DES) Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Drug Eluting Stents (DES) Typical Downstream Customers
- 14.4 Drug Eluting Stents (DES) Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
